150 related articles for article (PubMed ID: 30600644)
41. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.
Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC
ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654
[TBL] [Abstract][Full Text] [Related]
43. Anti-herpetic and anti-dengue activity of abietane ferruginol analogues synthesized from (+)-dehydroabietylamine.
Roa-Linares VC; Brand YM; Agudelo-Gomez LS; Tangarife-Castaño V; Betancur-Galvis LA; Gallego-Gomez JC; González MA
Eur J Med Chem; 2016 Jan; 108():79-88. PubMed ID: 26638041
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis and evaluation of 2'-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents.
Yan L; Cao R; Zhang H; Li Y; Li W; Li X; Fan S; Li S; Zhong W
Eur J Med Chem; 2021 Dec; 226():113852. PubMed ID: 34560428
[TBL] [Abstract][Full Text] [Related]
45. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
[TBL] [Abstract][Full Text] [Related]
46. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus.
Rothan HA; Buckle MJ; Ammar YA; Mohammadjavad P; Shatrah O; Noorsaadah AR; Rohana Y
Trop Biomed; 2013 Dec; 30(4):681-90. PubMed ID: 24522138
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs.
Matsuno K; Ueda Y; Fukuda M; Onoda K; Waki M; Ikeda M; Kato N; Miyachi H
Bioorg Med Chem Lett; 2014 Sep; 24(17):4276-80. PubMed ID: 25086684
[TBL] [Abstract][Full Text] [Related]
48. In vitro antiviral activities of extracts derived from Daucus maritimus seeds.
Miladi S; Abid N; Debarnôt C; Damak M; Canard B; Aouni M; Selmi B
Nat Prod Res; 2012; 26(11):1027-32. PubMed ID: 21895456
[TBL] [Abstract][Full Text] [Related]
49. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
50. New 2-Oxoimidazolidine Derivatives: Design, Synthesis and Evaluation of Anti-BK Virus Activities in Vitro.
Kornii Y; Chumachenko S; Shablykin O; Prichard MN; James SH; Hartline C; Zhirnov V; Brovarets V
Chem Biodivers; 2019 Oct; 16(10):e1900391. PubMed ID: 31479201
[TBL] [Abstract][Full Text] [Related]
51. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
[TBL] [Abstract][Full Text] [Related]
52. Antiviral activity of substituted salicylanilides--a review.
Krátký M; Vinšová J
Mini Rev Med Chem; 2011 Oct; 11(11):956-67. PubMed ID: 21762100
[TBL] [Abstract][Full Text] [Related]
53. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
Nitsche C; Steuer C; Klein CD
Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
[TBL] [Abstract][Full Text] [Related]
54. Computational insight into dengue virus NS2B-NS3 protease inhibition: A combined ligand- and structure-based approach.
Chen J; Jiang H; Li F; Hu B; Wang Y; Wang M; Wang J; Cheng M
Comput Biol Chem; 2018 Dec; 77():261-271. PubMed ID: 30393100
[TBL] [Abstract][Full Text] [Related]
55. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
[TBL] [Abstract][Full Text] [Related]
56. 5'-O-masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents.
Ikejiri M; Ohshima T; Kato K; Toyama M; Murata T; Shimotohno K; Maruyama T
Bioorg Med Chem; 2007 Nov; 15(22):6882-92. PubMed ID: 17766124
[TBL] [Abstract][Full Text] [Related]
57. In silico designing and screening of lead compounds to NS5-methyltransferase of dengue viruses.
Sivakumar D; Sivaraman T
Med Chem; 2011 Nov; 7(6):655-62. PubMed ID: 22313305
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and anti-enterovirus activity of new analogues of MDL-860.
Dobrikov GM; Slavchev I; Nikolova I; Stoyanova A; Nikolova N; Mukova L; Nikolova R; Shivachev B; Galabov AS
Bioorg Med Chem Lett; 2017 Oct; 27(19):4540-4543. PubMed ID: 28870395
[TBL] [Abstract][Full Text] [Related]
59. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
Parkinson T; Pryde DC
Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
